EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Effect of Remote Ischemic Conditioning in Patients Treated with Endovascular Therapy: A RESIST Trial Post Hoc Study

Rolf Ankerlund Blauenfeldt, David Charles Hess, David Gaist, Boris Modrau, Jan Brink Valentin, Søren Paaske Johnsen, Niels Hjort, Anne Brink Behrndtz, Martin Faurholdt Gude, Wenbo Zhao, Jonas Jensen, Grethe Andersen und 1 weitere

Translational Stroke Research · 2025

DOI: 10.1007/s12975-025-01379-5 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Translational Stroke Research, 2025. Verfasst von Rolf Ankerlund Blauenfeldt und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Aarhus University Hospital, Palle Juul Jensens Boulevard 165, Entrance J 518, 8200, Aarhus N, Aarhus, Denmark. rolfblau@rm.d…. Hauptthemen laut MEDLINE: Endovascular Procedures, Ischemic Stroke, Ischemic Preconditioning. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TrygFonden, National Institute of Health, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Remote ischemic conditioning (RIC) is a simple, non-invasive procedure that has been shown to be safe and feasible in multiple smaller clinical trials. Recent large randomized controlled trials have yielded mixed results regarding clinical effect. Patients with severe stroke may experience greater benefit from cerebroprotective interventions, highlighting the need for adjunctive therapies to enhance endovascular therapy (EVT) outcomes. This post hoc analysis of the RESIST trial evaluates the effect of RIC in the subgroup of patients who underwent EVT. Eligible patients were adults (≥ 18 years old), independent in activities of daily living, who had prehospital stroke symptoms with a duration of less than 4 h. They were randomized to RIC or sham. The primary analysis was performed using the entire range (“shift analysis”) of the modified Rankin scale (mRS) at 90 days. A total of 737 patients had acute ischemic stroke, and 134 received EVT. The median (IQR) age was 74 (62, 82) years, median NIHSS was 16 (8, 20), and 52 (39%) were female. Median (IQR) overall adherence to RIC/sham was 81% (56, 96). Intravenous thrombolysis (IVT) was initiated in 76 out of the 134 (57%) EVT-treated patients. There was no significant effect of RIC on mRS in EVT-treated patients, OR (95% CI) 1.26 (0.68–2.32). When IVT was given in addition to EVT, RIC was associated with improved functional outcome at 90 days, adjusted OR 2.46 (1.05, 5.78), p = 0.038 but not without adjunctive IVT, aOR 0.57 (0.21–1.53). The effect of RIC was present only in patients achieving complete reperfusion (mTICI 3) following EVT and IVT (54 out of 134 patients). RIC treatment in addition to IVT and EVT was associated with significantly improved functional outcome at 90 days, observed only in patients who achieved complete reperfusion. These results should only serve as hypothesis-generating for future trials. ClinicalTrials.gov:NCT03481777.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endovascular ProceduresIschemic StrokeIschemic PreconditioningHumansFemaleMaleAgedMiddle AgedAged, 80 and overTreatment Outcome

Stichwörter der Autor:innen

Acute ischemic strokeCerebroprotectionEndovascular therapyIntravenous thrombolysisNeuroprotectionRemote ischemic conditioningStroke

Autor:innen und Institutionen

  • Department of Neurology, Aarhus University Hospital, Palle Juul Jensens Boulevard 165, Entrance J 518, 8200, Aarhus N, Aarhus, Denmark. rolfblau@rm.dk.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. rolfblau@rm.dk.
  • Department of Neurology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
  • Research Unit for Neurology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
  • Department of Neurology, Aalborg University Hospital, Aalborg, Denmark.
  • Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Förderung

  • TrygFonden
  • National Institute of Health
  • Novo Nordisk Fonden
  • Manufacturer Vilhelm Pedersen and Wife's foundation
  • Aase and Ejnar Danielsens Foundation
  • Manufacturer Vilhelm Pedersen and Wife’s foundation
  • Aarhus University Hospital

Zitieren

APA

Blauenfeldt, R. A., Hess, D. C., Gaist, D., Modrau, B., Valentin, J. B., Johnsen, S. P., Hjort, N., Behrndtz, A. B., Gude, M. F., Zhao, W., Jensen, J., Andersen, G., & Simonsen, C. Z. (2025). The Effect of Remote Ischemic Conditioning in Patients Treated with Endovascular Therapy: A RESIST Trial Post Hoc Study. Translational Stroke Research. https://doi.org/10.1007/s12975-025-01379-5

Vancouver

Blauenfeldt RA, Hess DC, Gaist D, Modrau B, Valentin JB, Johnsen SP, et al. The Effect of Remote Ischemic Conditioning in Patients Treated with Endovascular Therapy: A RESIST Trial Post Hoc Study. Translational Stroke Research. 2025. doi:10.1007/s12975-025-01379-5

BibTeX
@article{Blauenfeldt2025,
  author = {Blauenfeldt, Rolf Ankerlund and Hess, David Charles and Gaist, David and Modrau, Boris and Valentin, Jan Brink and Johnsen, Søren Paaske and Hjort, Niels and Behrndtz, Anne Brink and Gude, Martin Faurholdt and Zhao, Wenbo and Jensen, Jonas and Andersen, Grethe and Simonsen, Claus Ziegler},
  title = {The Effect of Remote Ischemic Conditioning in Patients Treated with Endovascular Therapy: A RESIST Trial Post Hoc Study},
  journal = {Translational Stroke Research},
  year = {2025},
  doi = {10.1007/s12975-025-01379-5}
}
Kostenlos starten →